Stakeholder Perspectives on CMS’s 2022 Notice of Benefit and Payment Parameters. Part 2: State Insurance Departments and Marketplaces

In one of the Trump administration’s last acts, the Centers for Medicare and Medicaid Services finalized some of the major provisions of the 2022 Notice of Benefit and Payment Parameters. In the second part of our blog series reviewing stakeholder comments, CHIR’s Rachel Schwab takes a look at how state insurance departments and state-based marketplaces responded to some of the recently finalized proposals. Continue reading

The Administration Tried to Make It Easier for States to Waive ACA Rules: Will Any Take the Plunge?

Recent federal guidance made significant changes to the ACA’s section 1332 waiver program in order to give states greater leeway to sidestep ACA rules. But the move has triggered questions about whether the waiver options the Trump administration is touting are practical for states, or even legal. In a new work for The Commonwealth Fund, Justin Giovannelli and JoAnn Volk examine how states are approaching ACA waivers in the wake of the federal policy change. Continue reading

Trump Administration Hands States Another Tool for Dismantling Preexisting Condition Protections

Last week, the Trump administration issued long-anticipated guidance regarding the ACA’s Section 1332 “innovation waiver” program. The guidance breaks dramatically with past policy and, arguably, with the statute it purports to interpret, inviting states to undermine coverage for people with preexisting conditions. CHIR’s Justin Giovannelli analyzes the guidance and its implications. Continue reading